Cytosorbents (CTSO) Asset Writedowns and Impairment (2022 - 2026)
Cytosorbents' Asset Writedowns and Impairment was $38,000 in Q2 2026, down 84.5% from $245,000 a year earlier and down 87.3% from the prior quarter.
Cytosorbents (CTSO) Asset Writedowns and Impairment (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Cytosorbents' Asset Writedowns and Impairment was $338,000 through Jun 30, 2026, up 0.4% year-over-year; for FY2025, it came in at $253,000, down 24.2% from FY2024.
- Asset Writedowns and Impairment shows a three-year compound annual growth rate of -26.4% (FY2022 to FY2025).
- In earlier years, Asset Writedowns and Impairment was $333,735 in FY2024 (-49.1%), $655,685 in FY2023 (+3.2%) and $635,606 in FY2022.
- The Q2 2026 figure marks the lowest quarterly Asset Writedowns and Impairment since Q1 2025.
- Compared with a year earlier, Asset Writedowns and Impairment was higher in 1 of the last five quarters, with an average decline of 58.8%.
- The best year-over-year quarter for Asset Writedowns and Impairment over five years was Q2 2023 (growth of 44.2%); the worst was Q4 2024 (a decline of 88.5%).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn |
| 10 | Cytosorbents | 12.73 Mn | -10.29 Mn | 7.05 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Jun 30, 2025 | 245,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | 20,735.00 |
| Sep 30, 2024 | 63,000.00 |
| Jun 30, 2024 | 185,704.00 |
| Mar 31, 2024 | 64,296.00 |
| Dec 31, 2023 | 180,064.00 |
| Sep 30, 2023 | 182,815.00 |
| Jun 30, 2023 | 181,582.00 |
| Mar 31, 2023 | 111,224.00 |
| Dec 31, 2022 | 204,180.00 |
| Jun 30, 2022 | 125,921.00 |
| Mar 31, 2022 | 305,505.00 |
Cytosorbents Asset Writedowns and Impairment API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=CTSO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-writedowns-and-impairment", "ticker": "CTSO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=CTSO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();